The DOI matches its Crossref record; 168 of the 168 references it cites were found in a registry or an index.
The role of inflammation and microglial activation in the pathophysiology of psychiatric disorders
Abstract
Psychiatric disorders, including major depressive disorder (MDD), bipolar disorder (BD) and schizophrenia, affect a significant percentage of the world population. These disorders are associated with educational difficulties, decreased productivity and reduced quality of life, but their underlying pathophysiological mechanisms are not fully elucidated. Recently, studies have suggested that psychiatric disorders could be considered as inflammatory disorders, even though the exact mechanisms underlying this association are not known. An increase in inflammatory response and oxidative stress may lead to inflammation, which in turn can stimulate microglia in the brain. Microglial activation is roused by the M1 phenotype, which is associated with an increase in interleukin-1β (IL-1β) and tumor necrosis factor-α (TNF-α). On the contrary, M2 phenotype is associated with a release of anti-inflammatory cytokines. Thus, it is possible that the inflammatory response from microglial activation can contribute to brain pathology, as well as influence treatment responses. This review will highlight the role of inflammation in the pathophysiology of psychiatric disorders, such as MDD, BD, schizophrenia, and autism. More specifically, the role of microglial activation and associated molecular cascades will also be discussed as a means by which these neuroinflammatory mechanisms take place, when appropriate.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Inflammation is also likely to be an aggravating factor in the effects of NMDAR hypofunction and oxidative stress: prenatal immune challenge by the viral mimetic Polyl:C causes a long-lasting sensitivity of the offspring to peri-pubertal stress and NMDAR antagonists 90 .”
From Linking early-life NMDAR hypofunction and oxidative stress in schizophrenia pathogenesis (2016) · cites this paper as [90]
Citations
Cites
From inflammation to sickness and depression: when the immune system subjugates the brain
Dantzer, R., O'Connor, J. C., Freund, G. G., Johnson, R. W., & Kelley, K. W. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2297 · Cited by 7,395
Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo
Nimmerjahn, A., Kirchhoff, F., & Helmchen, F. (2005) · Science · doi:10.1126/science.1110647 · Cited by 5,827
Antidepressant effects of ketamine in depressed patients
Berman, R. M., Cappiello, A., Anand, A., Oren, D. A., Heninger, G. R., Charney, D. S., & Krystal, J. H. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00230-9 · Cited by 3,856
Inflammation and Its Discontents: The Role of Cytokines in the Pathophysiology of Major Depression
Miller, A. H., Maletic, V., & Raison, C. L. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.11.029 · Cited by 3,848
A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression.
Zarate, C. A., Singh, J. B., Carlson, P. J., Brutsche, N. E., Ameli, R., Luckenbaugh, D. A., Charney, D. S., & Manji, H. K. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.8.856 · Cited by 3,766
Advances in autism genetics: on the threshold of a new neurobiology
Abrahams, B. S., & Geschwind, D. H. (2008) · Nature Reviews Genetics · doi:10.1038/nrg2346 · Cited by 1,866
Microglial physiology: unique stimuli, specialized responses
Ransohoff, R. M., & Perry, V. H. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132528 · Cited by 1,858
Meta-Analysis of Cytokine Alterations in Schizophrenia: Clinical Status and Antipsychotic Effects
Miller, B. J., Buckley, P., Seabolt, W., Mellor, A., & Kirkpatrick, B. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.04.013 · Cited by 1,742
Control of microglial neurotoxicity by the fractalkine receptor
Cardona, A. E., Pioro, E. P., Sasse, M. E., Kostenko, V., Cardona, S. M., Dijkstra, I. M., Huang, D., Kidd, G., Dombrowski, S., Dutta, R., et al. (2006) · Nature Neuroscience · doi:10.1038/nn1715 · Cited by 1,531
Microglial and macrophage polarization—new prospects for brain repair
Hu, X., Leak, R. K., Shi, Y., Suenaga, J., Gao, Y., Zheng, P., & Chen, J. (2015) · Nature Reviews Neurology · doi:10.1038/nrneurol.2014.207 · Cited by 1,366
Research works printed but not linked: 2
- Abelaira, 2014, Animal models as tools to study the pathophysiology of depression, Rev Bras Psiquiatr, 35, 112, 10.1590/1516-4446-2013-1098 · DOI
- Gubert, 2013, The P2X7 purinergic receptor as a molecular target in Bipolar Disorder, Neuropsychiat Neuropsychol, 8, 1
Cited by
Sorted by citations
Burokas, A., Arboleya, S., Moloney, R. D., Peterson, V. L., Murphy, K., Clarke, G., Stanton, C., Dinan, T. G., & Cryan, J. F. (2017) · Biological Psychiatry · doi:10.1016/j.biopsych.2016.12.031 · Cited by 952
Akkasheh, G., Kashani-Poor, Z., Tajabadi-Ebrahimi, M., Jafari, P., Akbari, H., Taghizadeh, M., Memarzadeh, M. R., Asemi, Z., & Esmaillzadeh, A. (2016) · Nutrition · doi:10.1016/j.nut.2015.09.003 · Cited by 767
Passos, I. C., Vasconcelos-Moreno, M. P., Costa, L. G., Kunz, M., Brietzke, E., Quevedo, J., Salum, G., Magalhães, P. V., Kapczinski, F., & Kauer-Sant'Anna, M. (2015) · The Lancet Psychiatry · doi:10.1016/s2215-0366(15)00309-0 · Cited by 743
Self-citationCalcia, M., Bonsall, D. R., Bloomfield, P. S., Selvaraj, S., Barichello, T., & Howes, O. D. (2016) · Psychopharmacology · doi:10.1007/s00213-016-4218-9 · Cited by 748
Self-citationBrites, D., & Fernandes, A. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00476 · Cited by 599
“In addition, minocycline, which is a suppressor of activated microglia, has been shown to exert protective effects by reducing microglial activation, oxidative stress and inflammation (Réus et al., 2015).”
BackgroundInflammation, glutamate, and glia: a trio of trouble in mood disorders
Haroon, E., Miller, A. H., & Sanacora, G. (2017) · Neuropsychopharmacology · doi:10.1038/npp.2016.199 · Cited by 584
Microglia in depression: an overview of microglia in the pathogenesis and treatment of depression
Wang, H., He, Y., Sun, Z., Ren, S., Liu, M., Wang, G., & Yang, J. (2022) · Journal of Neuroinflammation · doi:10.1186/s12974-022-02492-0 · Cited by 605
Deficient autophagy in microglia impairs synaptic pruning and causes social behavioral defects
Kim, H.-J., Cho, M.-H., Shim, W. H., Kim, J. K., Jeon, E.-Y., Kim, D.-H., & Yoon, S.-Y. (2017) · Molecular Psychiatry · doi:10.1038/mp.2016.103 · Cited by 475
Bidirectional Microglia–Neuron Communication in Health and Disease
Szepesi, Z., Manouchehrian, O., Bachiller, S., & Deierborg, T. (2018) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2018.00323 · Cited by 459
Depression and chronic pain in the elderly: links and management challenges
Zis, P., Daskalaki, A., Bountouni, I., Sykioti, P., Varrassi, G., & Paladini, A. (2017) · Clinical Interventions in Aging · doi:10.2147/cia.s113576 · Cited by 458
Inflammation and post‐traumatic stress disorder
Hori, H., & Kim, Y. (2019) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.12820 · Cited by 437
Postmortem evidence of cerebral inflammation in schizophrenia: a systematic review
Trépanier, M. O., Hopperton, K. E., Mizrahi, R., Mechawar, N., & Bazinet, R. P. (2016) · Molecular Psychiatry · doi:10.1038/mp.2016.90 · Cited by 360
Neuroinflammation as a risk factor for attention deficit hyperactivity disorder
Dunn, G. A., Nigg, J. T., & Sullivan, E. L. (2019) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2019.05.005 · Cited by 299
dos Santos, R. G., Osório, F. L., Crippa, J. A. S., Riba, J., Zuardi, A. W., & Hallak, J. E. C. (2016) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125316638008 · Cited by 306
Linking early-life NMDAR hypofunction and oxidative stress in schizophrenia pathogenesis
Hardingham, G. E., & Do, K. Q. (2016) · Nature Reviews Neuroscience · doi:10.1038/nrn.2015.19 · Cited by 304
Blood-brain barrier permeability and physical exercise
Małkiewicz, M. A., Szarmach, A., Sabisz, A., Cubała, W. J., Szurowska, E., & Winklewski, P. J. (2019) · Journal of Neuroinflammation · doi:10.1186/s12974-019-1403-x · Cited by 276
Robertson, R. C., Seira Oriach, C., Murphy, K., Moloney, G. M., Cryan, J. F., Dinan, T. G., Paul Ross, R., & Stanton, C. (2017) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2016.07.145 · Cited by 268
Pathophysiological Role of Neuroinflammation in Neurodegenerative Diseases and Psychiatric Disorders
Hong, H., Kim, B. S., & Im, H. (2016) · International Neurourology Journal · doi:10.5213/inj.1632604.302 · Cited by 269
Classical psychedelics for the treatment of depression and anxiety: A systematic review
Muttoni, S., Ardissino, M., & John, C. (2019) · Journal of Affective Disorders · doi:10.1016/j.jad.2019.07.076 · Cited by 256
Rosenblat, J., & McIntyre, R. (2017) · Brain Sciences · doi:10.3390/brainsci7110144 · Cited by 258
Costello, H., Gould, R. L., Abrol, E., & Howard, R. (2019) · BMJ Open · doi:10.1136/bmjopen-2018-027925 · Cited by 248
Gut microbiota–brain axis in depression: the role of neuroinflammation
Carlessi, A. S., Borba, L. A., Zugno, A. I., Quevedo, J., & Réus, G. Z. (2021) · European Journal of Neuroscience · doi:10.1111/ejn.14631 · Cited by 243
Self-citationBiological hypotheses and biomarkers of bipolar disorder
Sigitova, E., Fišar, Z., Hroudová, J., Cikánková, T., & Raboch, J. (2016) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.12476 · Cited by 257
Aggression, Social Stress, and the Immune System in Humans and Animal Models
Takahashi, A., Flanigan, M. E., McEwen, B. S., & Russo, S. J. (2018) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2018.00056 · Cited by 239
Oxidative Stress‐Related Mechanisms in Schizophrenia Pathogenesis and New Treatment Perspectives
Ermakov, E. A., Dmitrieva, E. M., Parshukova, D. A., Kazantseva, D. V., Vasilieva, A. R., & Smirnova, L. P. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/8881770 · Cited by 256
Microglial activation and progressive brain changes in schizophrenia
Laskaris, L., Biase, M. A. D., Everall, I., Chana, G., Christopoulos, A., Skafidas, E. S., Cropley, V., & Pantelis, C. (2015) · British Journal of Pharmacology · doi:10.1111/bph.13364 · Cited by 237
Stress-induced plasticity and functioning of ventral tegmental dopamine neurons
Douma, E. H., & de Kloet, E. R. (2019) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2019.10.015 · Cited by 235
The roles of inflammation and immune mechanisms in Alzheimer's disease
Eldik, L. J. V., Carrillo, M. C., Cole, P. E., Feuerbach, D., Greenberg, B., Hendrix, J. A., Kennedy, M. E., Kozauer, N., Margolin, R. A., Molinuevo, J. L., et al. (2016) · Alzheimer s & Dementia Translational Research & Clinical Interventions · doi:10.1016/j.trci.2016.05.001 · Cited by 238
Current perspectives on gut microbiome dysbiosis and depression
Capuco, A., Urits, I., Hasoon, J., Chun, R., Gerald, B., Wang, J. K., Kassem, H., Ngo, A. L., Abd-Elsayed, A., Simopoulos, T., et al. (2020) · Advances in Therapy · doi:10.1007/s12325-020-01272-7 · Cited by 216
Narayanaswami, V., Dahl, K., Bernard‐Gauthier, V., Josephson, L., Cumming, P. D., & Vasdev, N. (2018) · Molecular Imaging · doi:10.1177/1536012118792317 · Cited by 224
Areas of controversy in neuroprogression in bipolar disorder
Passos, I. C., Mwangi, B., Vieta, E., Berk, M., & Kapczinski, F. P. (2016) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12581 · Cited by 220
Self-citationMa, K., Zhang, H., & Baloch, Z. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17050733 · Cited by 211
The impact of machine learning techniques in the study of bipolar disorder: A systematic review
Librenza‐Garcia, D., Kotzian, B. J., Yang, J. M. K., Mwangi, B., Cao, B., Lima, L. N. P., Bermúdez, M. B., Boeira, M. V., Kapczinski, F. P., & Passos, I. C. (2017) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2017.07.004 · Cited by 203
Self-citationSong, C., Shieh, C., Wu, Y.-S., Kalueff, A. V., Gaikwad, S., & Su, K. (2016) · Progress in Lipid Research · doi:10.1016/j.plipres.2015.12.003 · Cited by 196
Towards an Immunophenotype of Schizophrenia: Progress, Potential Mechanisms, and Future Directions
Miller, B. J., & Goldsmith, D. R. (2016) · Neuropsychopharmacology · doi:10.1038/npp.2016.211 · Cited by 182
ter Meulen, W. G., Draisma, S., van Hemert, A. M., Schoevers, R. A., Kupka, R., Beekman, A. T. F., & Penninx, B. W. J. H. (2021) · Journal of Affective Disorders · doi:10.1016/j.jad.2021.02.004 · Cited by 195
The role of oxidative and nitrosative stress in accelerated aging and major depressive disorder
Maurya, P. K., Noto, C. D. S., Rizzo, L. B., Rios, A. C., Nunes, S. O. V., Barbosa, D. S., Sethi, S., Zeni‐Graiff, M., Mansur, R. B., Maes, M. H. J., et al. (2015) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2015.08.016 · Cited by 174
Dunleavy, C., Elsworthy, R. J., Upthegrove, R., Wood, S. J., & Aldred, S. (2022) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.13416 · Cited by 169
A Review on the Role of Inflammation in Attention-Deficit/Hyperactivity Disorder
Leffa, D. T., Torres, I. L. D. S., & Rohde, L. A. (2018) · NeuroImmunoModulation · doi:10.1159/000489635 · Cited by 171
Golia, M. T., Poggini, S., Alboni, S., Garofalo, S., Albanese, N. C., Viglione, A., Ajmone‐Cat, M. A., St-Pierre, A., Brunello, N., Limatola, C., et al. (2019) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2019.07.003 · Cited by 161
Physical Exercise and Neuroinflammation in Major Depressive Disorder
Ignácio, Z. M., da Silva, R. S., Plissari, M. E., Quevedo, J., & Réus, G. Z. (2019) · Molecular Neurobiology · doi:10.1007/s12035-019-01670-1 · Cited by 153
Self-citationHuang, C., Wang, P., Xu, X., Zhang, Y., Gong, Y. L., Hu, W., Gao, M., Wu, Y. H., Ling, Y., Zhao, X., et al. (2017) · Glia · doi:10.1002/glia.23241 · Cited by 149
Mast Cells, Neuroinflammation and Pain in Fibromyalgia Syndrome
Theoharides, T. C., Tsilioni, I., & Bawazeer, M. A. (2019) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2019.00353 · Cited by 162
Mechanical and Biological Interactions of Implants with the Brain and Their Impact on Implant Design
Prodanov, D., & Delbeke, J. (2016) · Frontiers in Neuroscience · doi:10.3389/fnins.2016.00011 · Cited by 152
Revisiting inflammation in bipolar disorder
Fries, G. R., Walss-Bass, C., Bauer, M. E., & Teixeira, A. L. (2019) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2018.12.006 · Cited by 147
Self-citationMicroglial priming of antigen presentation and adaptive stimulation in Alzheimer’s disease
Das, R., & Chinnathambi, S. (2019) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03132-2 · Cited by 147
The Role of Chemokines in the Pathophysiology of Major Depressive Disorder
Milenkovic, V. M., Stanton, E. H., Nothdurfter, C., Rupprecht, R., & Wetzel, C. H. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20092283 · Cited by 149
Lannes, N., Eppler, E., Etemad, S., Yotovski, P., & Filgueira, L. (2017) · Oncotarget · doi:10.18632/oncotarget.23106 · Cited by 155
Hakamata, Y., Suzuki, Y., Kobashikawa, H., & Hori, H. (2022) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2022.100994 · Cited by 159
Statins and Inflammation: New Therapeutic Opportunities in Psychiatry
Kim, S., Kang, H., Jhon, M., Kim, J., Lee, J., Walker, A. J., Agustini, B., Kim, J., & Berk, M. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00103 · Cited by 142
Pál, B. Z. (2018) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-018-2837-5 · Cited by 140
HSP60 plays a regulatory role in IL-1β-induced microglial inflammation via TLR4-p38 MAPK axis
Swaroop, S., Sengupta, N., Suryawanshi, A. R., Adlakha, Y. K., & Basu, A. (2016) · Journal of Neuroinflammation · doi:10.1186/s12974-016-0486-x · Cited by 135
Cattaneo, A., Ferrari, C., Uher, R., Bocchio‐Chiavetto, L., Riva, M. A., & Pariante, C. M. (2016) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyw045 · Cited by 130
The neuroimmunology of social-stress-induced sensitization
Biltz, R. G., Sawicki, C. M., Sheridan, J. F., & Godbout, J. P. (2022) · Nature Immunology · doi:10.1038/s41590-022-01321-z · Cited by 132
Immune Abnormalities in Autism Spectrum Disorder—Could They Hold Promise for Causative Treatment?
Gładysz, D., Krzywdzińska, A., & Hozyasz, K. K. (2018) · Molecular Neurobiology · doi:10.1007/s12035-017-0822-x · Cited by 134
Wu, J., Zhao, Z., Kumar, A., Lipinski, M. M., Loane, D. J., Stoica, B. A., & Faden, A. I. (2016) · Journal of Neurotrauma · doi:10.1089/neu.2015.4348 · Cited by 124
Mongan, D., Ramesar, M., Föcking, M., Cannon, M., & Cotter, D. (2020) · Early Intervention in Psychiatry · doi:10.1111/eip.12859 · Cited by 123
Wang, H.-T., Huang, F., Hu, Z., Zhang, W., Qiao, X., Huang, Y., Dai, R., Li, F., & Li, C.-Q. (2017) · Neurotoxicity Research · doi:10.1007/s12640-016-9696-3 · Cited by 126
Postmortem evidence of brain inflammatory markers in bipolar disorder: a systematic review
Giridharan, V. V., Sayana, P., Pinjari, O. F., Ahmad, N., da Rosa, M. I., Quevedo, J., & Barichello, T. (2019) · Molecular Psychiatry · doi:10.1038/s41380-019-0448-7 · Cited by 120
Self-citationRocha, R. B., Dondossola, E. R., Grande, A. J., Colonetti, T., Ceretta, L. B., Passos, I. C., Quevedo, J., & da Rosa, M. I. (2016) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2016.08.004 · Cited by 119
Self-citationDhiman, K., Blennow, K., Zetterberg, H., Martins, R. N., & Gupta, V. B. (2019) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03040-5 · Cited by 117
Sugama, S., Takenouchi, T., Hashimoto, M., Ohata, H., Takenaka, Y., & Kakinuma, Y. (2019) · Journal of Neuroinflammation · doi:10.1186/s12974-019-1632-z · Cited by 119
Li, B., Liu, J., Gu, G., Han, X., Zhang, Q., & Zhang, W. (2020) · Journal of Neurochemistry · doi:10.1111/jnc.15001 · Cited by 110
Neuroprotection through flavonoid: Enhancement of the glyoxalase pathway
Frandsen, J. R., & Narayanasamy, P. (2017) · Redox Biology · doi:10.1016/j.redox.2017.10.015 · Cited by 118
Mitochondria, Microglia, and the Immune System—How Are They Linked in Affective Disorders?
Culmsee, C., Michels, S., Scheu, S., Arolt, V., Dannlowski, U., & Alferink, J. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2018.00739 · Cited by 110
Hippocampal volume and verbal memory performance in late-stage bipolar disorder
Cao, B., Passos, I. C., Mwangi, B., Bauer, I. E., Zunta‐Soares, G. B., Kapczinski, F. P., & Soares, J. C. (2015) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2015.12.012 · Cited by 113
Self-citationSomatic Comorbidity in Schizophrenia: Some Possible Biological Mechanisms Across the Life Span
Dieset, I., Andreassen, O. A., & Haukvik, U. K. (2016) · Schizophrenia Bulletin · doi:10.1093/schbul/sbw028 · Cited by 110
Role of interleukin 8 in depression and other psychiatric disorders
Tsai, S. (2020) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2020.110173 · Cited by 107
Han, L. K. M., Verhoeven, J. E., Tyrka, A. R., Penninx, B. W. J. H., Wolkowitz, O. M., Månsson, K. N. T., Lindqvist, D., Boks, M. P., Révész, D., Mellon, S. H., et al. (2019) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2019.04.004 · Cited by 104
“An increase in the inflammatory response, together with microglial activation, in turn, can contribute to psychiatric diseases, such as MDD, schizophrenia, BD, and autism (Khandaker et al., 2015; Martínez-Cengotitabengoa et al., 2016; Réus et al., 2015).”
Anti-TNF-α Compounds as a Treatment for Depression
Uzzan, S., & Azab, A. N. (2021) · Molecules · doi:10.3390/molecules26082368 · Cited by 112
Cognitive effects of adjunctive N-acetyl cysteine in psychosis
Rapado‐Castro, M., Dodd, S., Bush, A. I., Malhi, G. S., Skvarc, D., On, Z. X., Berk, M., & Dean, O. M. (2016) · Psychological Medicine · doi:10.1017/s0033291716002932 · Cited by 103
Non-linear association between composite dietary antioxidant index and depression
Zhao, L., Sun, Y., Cao, R., Wu, X., Huang, T., & Peng, W. (2022) · Frontiers in Public Health · doi:10.3389/fpubh.2022.988727 · Cited by 106
Chang, M., Womer, F. Y., Edmiston, E. K., Bai, C., Zhou, Q., Jiang, X., Wei, S., Wei, Y., Ye, Y., Huang, H., et al. (2017) · Schizophrenia Bulletin · doi:10.1093/schbul/sbx028 · Cited by 102
Athira, K. V., Bandopadhyay, S., Samudrala, P. K., Naidu, V. G. M., Lahkar, M., & Chakravarty, S. (2019) · Current Neuropharmacology · doi:10.2174/1570159x17666191001142934 · Cited by 110
Du, R., Wu, F.-F., Lu, M., Shu, X.-D., Ding, J.-H., Wu, G., & Hu, G. (2016) · Redox Biology · doi:10.1016/j.redox.2016.08.006 · Cited by 100
Prenatal Stress and the Developing Brain: Postnatal Environments Promoting Resilience
Nolvi, S., Merz, E. C., Kataja, E., & Parsons, C. E. (2022) · Biological Psychiatry · doi:10.1016/j.biopsych.2022.11.023 · Cited by 124
Tsai, S.-J. (2017) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2017.06.001 · Cited by 98
Wang, P., Zhang, Y., Gong, Y., Yang, R., Chen, Z., Hu, W., Wu, Y., Gao, M., Xu, X., Qin, Y., et al. (2018) · Neurobiology of Disease · doi:10.1016/j.nbd.2017.12.006 · Cited by 97
Neuroinflammation in Post-Traumatic Stress Disorder
Lee, D.-H., Lee, J.-Y., Hong, D.-Y., Lee, E.-C., Park, S.-W., Lee, M. R., & Oh, J. S. (2022) · Biomedicines · doi:10.3390/biomedicines10050953 · Cited by 102
Biomarkers for bipolar disorder: current status and challenges ahead
Teixeira, A. L., Colpo, G. D., Fries, G. R., Bauer, I. E., & Selvaraj, S. (2018) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2019.1550361 · Cited by 95
Self-citationGut microbiome interventions in human health and diseases
Nie, P., Li, Z., Wang, Y., Zhang, Y., Zhao, M., Luo, J., Du, S., Deng, Z., Chen, J., Wang, Y., et al. (2019) · Medicinal Research Reviews · doi:10.1002/med.21584 · Cited by 94
Draper, A., Koch, R. M., van der Meer, J. W., Apps, M. A. J., Pickkers, P., Husain, M., & van der Schaaf, M. E. (2017) · Neuropsychopharmacology · doi:10.1038/npp.2017.231 · Cited by 94
Purinergic receptors in psychiatric disorders
Krügel, U. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.10.032 · Cited by 96
Bavato, F., Barro, C., Schnider, L. K., Simrén, J., Zetterberg, H., Seifritz, E., & Quednow, B. B. (2024) · Molecular Psychiatry · doi:10.1038/s41380-024-02524-6 · Cited by 94
Modulation of microglial activation by antidepressants
Mariani, N., Everson, J., Pariante, C. M., & Borsini, A. (2022) · Journal of Psychopharmacology · doi:10.1177/02698811211069110 · Cited by 92
Tidmarsh, L. V., Harrison, R. N., Ravindran, D., Matthews, S. L., & Finlay, K. A. (2022) · Frontiers in Pain Research · doi:10.3389/fpain.2022.923866 · Cited by 102
Antioxidant Properties of Second-Generation Antipsychotics: Focus on Microglia
Caruso, G., Grasso, M., Fidilio, A., Tascedda, F., Drago, F., & Caraci, F. (2020) · Pharmaceuticals · doi:10.3390/ph13120457 · Cited by 91
Sex differences in the blood–brain barrier: Implications for mental health
Dion‐Albert, L., Binder, L. B., Daigle, B., Hong-Minh, A., Lebel, M., & Ménard, C. (2022) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2022.100989 · Cited by 93
DNA Methylation Signatures of Mood Stabilizers and Antipsychotics in Bipolar Disorder
Houtepen, L. C., van Bergen, A. H., Vinkers, C. H., & Boks, M. P. (2016) · Epigenomics · doi:10.2217/epi.15.98 · Cited by 90
A survey of neuroimmune changes in pregnant and postpartum female rats
Haim, A., Julian, D. L., Albin-Brooks, C., Brothers, H. M., Lenz, K. M., & Leuner, B. (2016) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2016.09.026 · Cited by 86
Oleoylethanolamide, Neuroinflammation, and Alcohol Abuse
Orío, L., Alén, F., Pavón, F. J., Serrano, A., & García‐Bueno, B. (2019) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00490 · Cited by 91
Li, H., Zhang, Q., Li, N., Wang, F., Xiang, H., Zhang, Z., Su, Y., Huang, Y., Zhang, S., Zhao, G., et al. (2016) · Psychiatry Research · doi:10.1016/j.psychres.2016.10.061 · Cited by 85
Molecular signature of extracellular matrix pathology in schizophrenia
Pantazopoulos, H., Katsel, P., Haroutunian, V. H., Chelini, G., Klengel, T., & Berretta, S. (2020) · European Journal of Neuroscience · doi:10.1111/ejn.15009 · Cited by 83
Bhattacharya, A., Lord, B., Grigoleit, J., He, Y., Fraser, I. C., Campbell, S. N., Taylor, N., Aluisio, L. E., O’Connor, J. C., Papp, M., et al. (2018) · Neuropsychopharmacology · doi:10.1038/s41386-018-0141-6 · Cited by 84
Welcome, M. O. (2020) · Inflammopharmacology · doi:10.1007/s10787-020-00712-8 · Cited by 85
A unified model of the pathophysiology of bipolar disorder
Magioncalda, P., & Martino, M. (2021) · Molecular Psychiatry · doi:10.1038/s41380-021-01091-4 · Cited by 98
Biase, M. A. D., Zalesky, A., Karayumak, S. C., Yogesh Rathi, A., Lv, J., Boerrigter, D., North, H. F., Tooney, P. A., Pantelis, C., Pasternak, O., et al. (2020) · Schizophrenia Bulletin · doi:10.1093/schbul/sbaa134 · Cited by 80
Réus, G. Z., Fernandes, G. C., de Moura, A. B., da Silva, R. H., Darabas, A. C., de Souza, T. G., Abelaira, H. M., Carneiro, C., Wendhausen, D. L., Michels, M., et al. (2017) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2017.08.020 · Cited by 84
Self-citationTan, X., Du, X., Jiang, Y., Botchway, B. O. A., Hu, Z., & Fang, M. (2018) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2018.00434 · Cited by 80
Minter, M. R., Moore, Z., Zhang, M., Brody, K. M., Jones, N. C., Shultz, S. R., Taylor, J. M., & Crack, P. J. (2016) · Acta Neuropathologica Communications · doi:10.1186/s40478-016-0341-4 · Cited by 79
Metadata
- Authors
- Réus, G. Z., Fries, G. R., Stertz, L., Badawy, M., Passos, I. C., Barichello, T., Kapczinski, F., & Quevedo, J.
- Affiliations
- Universidade do Extremo Sul Catarinense (BR)
- Universidade Federal do Rio Grande do Sul (BR)
- The University of Texas Health Science Center at Houston (US)
- Corresponding author
- Réus, G.Z.
- Venue
- Neuroscience
- Publisher
- Elsevier BV
- Published
- 2015-08
- Volume
- 300
- Pages
- 141-154
- ISSN
- 0306-4522 (ISSN-L)
- OpenAlex
- W297523562
- Cited by
- 594
- References
- 168
- Citations by year
- 2026: 30 · 2025: 42 · 2024: 33 · 2023: 42 · 2022: 69 · 2021: 69 · 2020: 55 · 2019: 76 · 2018: 56 · 2017: 46 · 2016: 58 · 2015: 17
- FWCI
- 3.32
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Neuroscience (publishedVersion)
- PubMed (publishedVersion)
- Funders
- CNPq
- FAPESC
- UNESC
- ĹOréal/UNESCO/ABC Brazil Fellowship for Women in Science 2011
- The University of Texas Medical School at Houston
- Topics
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Keywords
- neuroinflammation, microglial activation, mental illness, major depressive disorder, bipolar disorder, schizophrenia, autism spectrum disorder, M1/M2 microglial polarization, IL-1β, TNF-α, oxidative stress, anti-inflammatory cytokines, treatment response
- MeSH terms
- Animals, Mental Disorders, Brain, Humans, Inflammation, Microglia
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review